Figure 7.

Mean scores on the Q-LES-Q-SF (0–80) for all patients (last observation carried forward) enrolled in a randomized, double-blind 12-week trial of antidepressant monotherapy vs combination treatment, including a double-blind 6-week augmentation in non-remitters, and a double-blind 6-month prolongation in both week 12 and week 18 remitters.
Abbreviation: Q-LES-Q-SF, Quality of Life Enjoyment and Satisfaction Questionnaire-short form.